Millions of Americans can now look forward to a better time traveling, with the US Food and Drug Administration (FDA) ...

Tradipitant is a selective human substance P/neurokinin-1 receptor antagonist approved for the prevention of vomiting induced by motion in adults.

Analysts raise price targets for Vanda Pharmaceuticals after FDA approved a motion sickness drug, citing growth potential.

Vanda also sells sleep disorder drug Hetlioz, which reached the market in 2014, and relapsing multiple sclerosis treatment ...

Vanda Pharmaceuticals has received FDA approval for Nereus (tradipitant), an oral NK-1 receptor antagonist developed to prevent motion-induced vomiting. The approval makes Nereus the first new ...

Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are ...

The FDA approved Vanda’s drug Nereus to prevent motion-induced vomiting, opening a potential path into treating nausea linked ...

The scopolamine skin patch (Transderm Scōp), approved in 1979, was the last drug sanctioned by the FDA to prevent motion ...

The US Food and Drug Administration (FDA) has approved Vanda Pharmaceuticals’ Nereus (tradipitant) for the prevention of ...

Motion sickness is something that has troubled most of us. While some may get over the feeling with time, others may continue to battle the woes of motion sickness throughout their life. "Motion ...

Growing up, Cortney Cook had to keep a bag nearby during road trips. Like many children, Cook suffered from motion sickness and that feeling of unease would last even after the long car ride would end ...

Motion sickness is an unpleasant sensation commonly seen in some vulnerable individuals when they are subjected to unnatural motion. All persons can develop motion sickness if given the right stimulus ...